Company Filing History:
Years Active: 2020-2024
Title: Innovator Spotlight: Sara Fradera Gelabert
Introduction: Sara Fradera Gelabert, an accomplished inventor based in Sant Boi de Llobregat, Spain, has made significant contributions to the pharmaceutical field. With a total of two patents to her name, she has focused on developing innovative tablet compositions that enhance medication efficacy and patient experience.
Latest Patents: Sara's latest patents include:
1. **Tablet compositions comprising abiraterone acetate** - This invention relates to a tablet composition designed for oral administration of abiraterone acetate. It emphasizes the creation of pharmaceutical granulates and tablets that ensure the immediate release of the drug in the stomach, enhancing its therapeutic effects.
2. **Pharmaceutical composition comprising ibrutinib** - This patent pertains to a tablet composition containing ibrutinib along with one or more pharmaceutically acceptable excipients. The invention is particularly focused on the treatment of chronic lymphocytic leukaemia (CLL), mantle cell lymphoma (MCL), and Waldenström's macroglobulinaemia (WM), marking a breakthrough in targeted therapies.
Career Highlights: Sara works at Synthon B.V., a company renowned for its commitment to developing innovative medicines. Her role involves leveraging her expertise in pharmaceutical formulation to advance the company's product offerings and enhance patient outcomes.
Collaborations: Throughout her career, Sara has collaborated with esteemed colleagues such as Lisardo Alvarez Fernandez and Rohit Kumar. These partnerships have facilitated the sharing of ideas and expertise, ultimately driving the success of her innovative projects.
Conclusion: With her dedication and innovative spirit, Sara Fradera Gelabert continues to influence the pharmaceutical industry significantly. Her work not only exemplifies the importance of innovation in medicine but also inspires the next generation of inventors striving to improve health outcomes worldwide.